Vericel Corp. (VCEL)
31.41
-1.33
(-4.06%)
USD |
NASDAQ |
Mar 20, 16:00
31.46
+0.05
(+0.16%)
After-Hours: 20:00
Vericel Market Cap : 1.594B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arbutus Biopharma Corp. | 815.45M |
| Moderna, Inc. | 20.29B |
| Marker Therapeutics, Inc. | 22.34M |
| X4 Pharmaceuticals, Inc. | 389.14M |
| ACADIA Pharmaceuticals, Inc. | 3.536B |
Market Cap Related Metrics
| PE Ratio | 102.05 |
| PS Ratio | 5.806 |
| PEG Ratio | 1.529 |
| Price to Book Value | 4.496 |
| Price to Free Cash Flow | 64.81 |
| Price | 31.41 |
| Earnings Yield | 0.98% |
| PEGY Ratio | 1.529 |
| Operating PE Ratio | 145.23 |
| Normalized PE Ratio | 102.05 |